Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Report Results
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Report Results
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

Deca Aloe Presents Newest Clinical Research Monograph Authored by World Expert Regarding Benefits of Aloe and Natural Raw Honey Therapy -- 'Organic Aloe and Natural Raw Honey as Nutraceuticals & Medical Foods'


News provided by

Deca Aloe

Feb 19, 2020, 08:41 ET

Share this article

Share toX

Share this article

Share toX

DALLAS, Feb. 19, 2020 /PRNewswire/ -- Deca Aloe (https://www.aloeproductscenter.com) recently announced the release of a new e/monograph from leading aloe vera and herbal remedy researcher Ivan E. Danhof, Ph.D., M.D. The e/monograph explores the extensive health benefits derived from infusions of organic aloe arborescens (a cousin to aloe vera) and natural raw honey, focusing specifically on the cancer fighting properties of both. The $30.00 e-Monograph was prepared for use by physicians and other healthcare and wellness professionals, and is available FREE at https://www.aloeproductscenter.com/researchmonograph-for-healthcareprofessionals/

Continue Reading
Revolutionary Natural Formula Scientifically Proven to Revitalize a Weakened Immune System with verified ingredients in over 4,000 studies. Positive reviews from Doctors and Health Care Professionals regarding the Aloe Arborescens Supreme Immune Health Formula™ on: https://www.aloeproductscenter.com/reviews/
Revolutionary Natural Formula Scientifically Proven to Revitalize a Weakened Immune System with verified ingredients in over 4,000 studies. Positive reviews from Doctors and Health Care Professionals regarding the Aloe Arborescens Supreme Immune Health Formula™ on: https://www.aloeproductscenter.com/reviews/
Doctors, Healthcare and Wellness Professionals can download a FREE review copy ($30.00 Value) of the Breakthrough Scientific Wellness e-Monograph for Doctors and Healthcare Professionals titled: "Organic Aloe and Natural Raw Honey as Nutraceuticals & Medical Foods at: https://www.aloeproductscenter.com/researchmonograph-for-healthcareprofessionals
Doctors, Healthcare and Wellness Professionals can download a FREE review copy ($30.00 Value) of the Breakthrough Scientific Wellness e-Monograph for Doctors and Healthcare Professionals titled: "Organic Aloe and Natural Raw Honey as Nutraceuticals & Medical Foods at: https://www.aloeproductscenter.com/researchmonograph-for-healthcareprofessionals

Aloe has a long and celebrated history in a variety of basic medical applications, though recent studies by experts like Dr. Danhof have revealed the growing pharmaceutical benefits of aloe, particularly against neoplastic diseases.

"Aloe species contain several very large polysaccharides (many sugars) consisting of glucose (blood sugar) and mannose (various plants) which, when administered to animals and humans, cause the release of substances from certain white blood cells that form and activate natural killer cells (NKC) that attack cancer cells and cause their demise (death)," Dr. Danhof wrote. "Unlike chemotherapy (destruction of cancer cells by chemicals) and radiotherapy (destruction by irradiation), stimulation of natural killer cells does not destroy normal cells in the body, as the only targets are cancer cells."

Dr. Danhof's most recent research centers on the actions of the immune system and its natural ability to fight off cancer by activating anti-cancer killer cells. These cells attach to cancer cells and destroy them directly. One of the greatest advantages of using the body's own system of defense is that the body is far more capable of targeting every single dangerous cell, unlike chemotherapy and other treatment modalities. Dr. Danhof also explores the various compounds within aloe arborescens, their activated uses, and the best carriers for those compounds; like organic honey, which also contains powerful anti-cancer properties.

About Dr. Ivan E. Danhof

Referred to as the "Father of Aloe," Dr. Danhof is considered to be one of the world's foremost experts on medically active herbal molecules, and is the world's leading expert on Aloe Vera. With over 30 years of laboratory research and practical experience, Dr. Danhof's work is frequently cited in research and marketing materials, while his formulas are highly sought-after in Brazil, Europe and worldwide.

Dr. Danhof did undergraduate work in biology and chemistry, before completing graduate work in microbiology, taking a master's degree. He subsequently earned another master's degree in nutrition and a Ph.D. in physiology from the University of Illinois before later earning his M.D. from the University of Texas Health Science Center, with medical specialties in internal medicine and gastroenterology. Dr. Danhof has published more than 80 research papers and served as the consultant to several pharmaceutical research institutes, in addition to being a consultant for the U.S. FDA.

Disclaimer: The information provided within this release is for informational purposes only and is not intended as a substitute for advice from a physician or other health care professional. A health care professional should be consulted before starting any diet, exercise or supplementation program.

About Deca Aloe Arborescens U.S. (www.DecaAloe.com)

Formed in 2007, Deca Aloe is a supplement manufacturer who designed and distributes its proprietary Supreme Immune Health Formula™ — an aloe arborescens and honey-based Nutraceutical Dietary Supplement originally discovered in Brazil and subsequently clinically tested in Italy. Serving individuals for over a decade, Deca Aloe offers consistent high-quality products that adhere to strict control protocols and regulatory compliance programs. Learn more at: www.AloeProductsCenter.com.

Media Contact:

Roger Dextor/VP
Phone: 631.924.3888
Email: [email protected]

https://www.facebook.com/AloeProductsCenter

https://twitter.com/Aloe_Formula

https://www.pinterest.com/aloeproductscenter

SOURCE Deca Aloe

Related Links

http://www.AloeProductsCenter.com

21%

more press release views with 
Request a Demo

Modal title

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2026 Cision US Inc.